Topics

Companies Related to "regulates fatty acid metabolism through multigenic program claudin" [Most Relevant Company Matches] RSS

23:54 EST 17th February 2020 | BioPortfolio

Here are the most relevant search results for "regulates fatty acid metabolism through multigenic program claudin" found in our extensive corporate database of over 50,000 company records.

Showing "regulates fatty acid metabolism through multigenic program claudin" Companies 1–25 of 2,000+

Extremely Relevant

Efamol ltd

Efamol specialises in essential fatty acid (EFAs) based products, the so called "good fats" that are essential for the healthy functioning of every cell in the human body. These "good fats" are from the Omega-3 and Omega-6 families of nutrients and are sourced from high quality fish oils and evening primrose oil. Since it's inception Efamol has developed a specialised range of fatty acid based pro...


Relevant

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics is a spin-off company from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids, that have the potential to treat inflammatory, cardiovascular, and other diseases. Epoxyeicosanoids as a newly desc...

OMEICOS Therapeutics

OMEICOS Therapeutics is a spin-off company from the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat inflammatory, cardiovascular and other diseases. Epoxyeicosanoids, as a newly describ...


Kerecis Limited

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid-rich products from the company’s patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring.

Edgewise Therapeutics

Edgewise Therapeutics was founded in 2017 by Alan Russell, Ph.D., Peter Thompson, M.D. (Orbimed Advisors) and Badreddin Edris, Ph.D., (Springworks Inc.) and is pioneering the development of first-in-class medicines for the treatment of high morbidity musculoskeletal diseases. Skeletal muscle is the largest organ system in the human body, regulating both force production to enable muscle contracti...

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is a specialty pharmaceuticals company with an experienced team of experts in drug development focusing its efforts on the clinical development of new therapies for dyslipidemia. The lead product candidate is Epanova™, an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic ...

Laurent Pharmaceuticals, Inc.

Laurent Pharmaceuticals is a clinical stage biopharmaceutical company focusing on rare diseases. The company is currentelly conducting a Phase 2 study evaluating the efficacy and safety of its lead drug candidate, LAU-7b (oral fenretinide), in adult patients with CF. LAU-7b is believed to act on the resolution phase of inflammation by endogenously modulating the metabolism of docosahexaenoic acid...

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewar...

Biolipox AB

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewar...

Bioriginal Food & Science Corp

Bioriginal delivers innovative essential fatty acid (EFA) solutions which are used around the world in nutraceuticals, functional foods, skin care products, cosmetics, animal feed, veterinary products and over-the-counter pharmaceuticals. Our distribution network spans six continents, with facilities in Canada, the United States, Europe and China.

Phytecs, Inc.

Phytecs is a biotechnology company developing interventions that address the endocannabinoid system (ECS). The Phytecs team pioneered the modern understanding of how the ECS regulates aspects of physiology including immunity, pain, inflammation, mood, emotion, learning, memory, metabolism, appetite, weight, sleep, embryo development, neuroprotection and st...

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across ...

Donboo Amino Acid Co., Ltd

Donboo Amino Acid Co., Ltd is an enterprise with advanced science and technology. We specialize in scientific research, manufacture & trade of amino acids and its derivations. It is over 10 years since we were devoted to the scientific research and development of amino acid. We have now established friendly trade contacts with many amino acid factories throughout the P.R.China. With a fully-ranged...

Cenestra Health

Cenestra Health is a privately-held New Haven, Connecticut based biotech company founded to formulate and market "best-in-class" proprietary natural products with applications in the OTC, medical food and pharmaceutical markets. Cenestra Health currently markets (www.omax3.com) its now proprietary pharmaceutical grade omega-3 fatty acid product Omax3®, The Ultra-Pure Omega-3 Supplement®, in the ...

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational m...

Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs in the inhibition ...

Pronutria Biosciences Inc.

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics. Amino acids (AA) are known as the “building blocks of life,” and are fundamental regulators of health. The entire body, ranging from microscopic cells to organs, is dependent on tightly controlled AA homeostasis. More than 2000 disorders are linked ...

PURAC

CSM Biochemicals is a division of CSM and operates in the marketplace under the name PURAC. Our parent company, CSM, is a company operating and engaged in the development, production, sale and distribution of bakery supplies and food ingredients. CSM is listed on the Euronext stock exchange in Amsterdam. CSM has a leading market position in bakery ingredients, sugar, lactic acid/lactates ...

Pronutria Biosciences

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics. Amino acids (AA) are known as the “building blocks of life,” and are fundamental regulators of health. The entire body, ranging from microscopic cells to organs, is dependent on tightly controlled AA homeostasis. More than 2000 disorders are linked ...

Nantong Acetic Acid Chemical Co., Ltd.

Nantong Acetic Acid Company limited (formerly Nantong Acetic Acid chemical factory),after 44years of creation and development,is a comprehensive chemical company producing acetic acid derivatives which is the largest in production scope and the most complete in varieties in China.its main product include more then 30 varieties in four series such as organic raw materials,pharmaceutical intermediat...

Jerry Cott, Ph.D

Jerry is a neuropsychopharmacologist specializing in clinical and preclinical psychotherapeutic drug development. Since obtaining his Ph.D. in pharmacology at the University of North Carolina in Chapel Hill, and a postdoctoral fellowship with Nobel Laureate, Arvid Carlsson, at the University of Göteborg, Sweden, he has had a variety of work experiences including: teaching medical school at the Un...

The Gout & Uric Acid Education Society

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and health care providers. For more information about gout and the Gout & Uric Acid Education Society, please visit www.gouteducation.org.

Agios Pharmaceuticals

Agios Pharmaceuticals is the first biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer metabolism. To support and drive these efforts, Agios is building a robust platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification...

Agilis Biotherapeutics, LLC

Agilis Biotherapeutics, LLC, is a biotechnology company focused on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are limited or no treatment options. We believe that engineered DNA-based therapeutics provide the ability to target ...

Myriant Technologies

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable manufacturing of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will next begin commercial production o...


More From BioPortfolio on "regulates fatty acid metabolism through multigenic program claudin"

Quick Search

Corporate Database Quicklinks